Lv52
1320 积分 2025-06-05 加入
Clinical Pharmacology and Translational Science Considerations in the Development of Dual‐Payload Antibody Drug Conjugates
1小时前
待确认
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
1小时前
已完结
Suppressive Immune Response of Poly(sarcosine) Conjugated Proteins: PSARylation
1个月前
已完结
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer
1个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
1个月前
已完结
Antibody–Bottlebrush Conjugates Unlock Diverse Payloads for Targeted Cancer Therapy
1个月前
已完结
Challenges and approaches to the design of hydrophilic linkers for antibody-drug conjugates
1个月前
已完结
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
5个月前
已完结
Chromatin remodellers as therapeutic targets
5个月前
已完结
Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment
7个月前
已完结
皖公网安备34019202002308
